Chemistry:CB-86
From HandWiki
CB-86 is a synthetic cannabinoid drug which was developed as a hybrid between classical/nonclassical cannabinoids such as THC and CP 47,497 with endogenous cannabinoid ligands such as anandamide. It acts as a partial agonist at CB1 receptors with a Ki of 5.6 nM, and an antagonist of CB2 receptors with a Ki of 7.9 nM. It has analgesic effects in studies on mice.[1]
See also
References
- ↑ "New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo". Journal of Medicinal Chemistry 52 (8): 2506–2514. April 2009. doi:10.1021/jm8016255. PMID 19331413.
 | 0.00  (0 votes) |
